France Veterinary Healthcare Market- Growth, Trends, and Forecast (2020 - 2025)

The France Veterinary Healthcare Market is segmented By Product (By Therapeutics, and By Diagnostics), and By Animal Type

Market Snapshot

Study Period:


Base Year:


80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Market Overview

There is a risk of emerging new strains of influenza viruses, due to the long-distance transportation of animals. The farms are often in the same area, with a concentration of confined animals, which potentially enhances the risk of avian influenza transferring to pigs. The reassortment of the virus can lead to new strains and cause infections among humans. Further, these farms increase the risk of spreading and mixing of virus strains. Intensive farm practices are causing the risk of emergence of these bacteria in the food, as stressed animals become more susceptible to infection. The risk of zoonotic diseases is fuelling the market for France veterinary healthcare. Additionally, advanced technology leading to innovations in animal healthcare is also a factor responsible for the growth of France veterinary healthcare market.

Advances in veterinary care over the past few years have come at a high price. For instance, costs to treat a torn Anterior Cruciate Ligament (ACL), a common dog injury, have soared to costs above 2,000 euros, which is more than double the money people had paid in past. That doesn't include the costs of diagnostic testing, which can add an additional cost to a pet owner's bill. Also, many diseases and injuries are diagnosed with an MRI, which used to be inaccessible to all but the most well-funded university hospitals. That MRI machines are available in many hospitals, vets use this test as standard care for diagnosing and treating cancer, epilepsy, injury, etc., but the test itself also costs around 600 plus euros as this is an incredibly useful and important diagnostic tool, the cost is out of reach for many pet owners who would struggle to be able to afford the surgery and/or treatment following the MRI, let alone the cost of the test itself. Thus, the increasing cost of animal testing and veterinary services is hindering the growth of the market to some extent. 

Scope of the Report

As per the scope of the report, Veterinary medicines are associated with treatment, diagnosis, and prevention of diseases among animals. It covers a variety of animal species, both, in domestic and wild.

Report scope can be customized per your requirements. Click here.

Key Market Trends

Vaccines is expected to lead the France Veterinary Healthcare Market

The Vaccines segment in France veterinary healthcare market is expected to register healthy growth during the forecast period due to the presence of good healthcare infrastructure in France and it is also experiencing positive trends in the R&D developments. Inter-Governmental Organizations are making reforms to ensure health through the process of surveillance and vaccination. Also, awareness about pet health care and diagnostic techniques in the veterinary health care market will drive the market.

To understand key trends, Download Sample Report

Competitive Landscape

The major players in the France Veterinary Healthcare Market include - Bayer Healthcare, Boehringer Ingelheim International GmbH, Ceva Animal Health, Inc., Elanco, IDEXX Laboratories, Merck & Co. Inc., Vetoquinol, and Zoetis Inc.

Table Of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Advanced Technology Leading to Innovations in Animal Healthcare

      2. 4.2.2 Risk of Emerging Zoonosis

    3. 4.3 Market Restraints

      1. 4.3.1 Lack of Infrastructure and Funding

      2. 4.3.2 Use of Counterfeit Medicines

      3. 4.3.3 Increasing Costs of Animal Testing and Veterinary Services

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Product

      1. 5.1.1 By Therapeutics

        1. Vaccines

        2. Parasiticides

        3. Anti-infectives

        4. Medical Feed Additives

        5. Other Therapeutics

      2. 5.1.2 By Diagnostics

        1. Immunodiagnostic Tests

        2. Molecular diagnostics

        3. Diagnostic Imaging

        4. Clinical Chemistry

        5. Other Diagnostics

    2. 5.2 By Animal Type

      1. 5.2.1 Dogs and Cats

      2. 5.2.2 Horses

      3. 5.2.3 Ruminants

      4. 5.2.4 Swine

      5. 5.2.5 Poultry

      6. 5.2.6 Other Animals


    1. 6.1 Company Profiles

      1. 6.1.1 Bayer Healthcare

      2. 6.1.2 Boehringer Ingelheim International GmbH

      3. 6.1.3 Ceva Animal Health, Inc.

      4. 6.1.4 Elanco

      5. 6.1.5 IDEXX Laboratories

      6. 6.1.6 Merck & Co. Inc.

      7. 6.1.7 Vetoquinol

      8. 6.1.8 Zoetis Inc.

  7. *List Not Exhaustive

** Subject to Availability

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

Related Reports